These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 690322)

  • 21. [Current prospects in the treatment of refractory congestive heart failure with high doses of insulin, glucose and potassium].
    Melloni GF; Lureti GF; Minoja GM; Melloni CF; Fassini G; Scarlatti GF; Facchetti M
    Boll Soc Ital Cardiol; 1977; 22(7):1073-9. PubMed ID: 618243
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat.
    Chang CC; Wang SS; Huang HC; Chan CY; Lee FY; Lin HC; Nong JY; Chuang CL; Lee SD
    Eur J Pharmacol; 2011 Sep; 666(1-3):226-32. PubMed ID: 21575628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin and glucose in the treatment of heart-failure.
    Majid PA; Sharma B; Meeran MK; Taylor SH
    Lancet; 1972 Nov; 2(7784):937-41. PubMed ID: 4116822
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mechanism and therapy of hyponatremia with central origin].
    Morinaga K; Tabuse H; Ohkawara S
    No Shinkei Geka; 1989 Jun; 17(6):539-44. PubMed ID: 2693988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is an initial small-spectrum antibiotic regimen safe in fulminant hepatic failure?
    Clemmesen J; Larsen F; Rasmussen A; Hansen B
    Transplant Proc; 1995 Dec; 27(6):3505. PubMed ID: 8540071
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurologic consequences of fulminant hepatic failure.
    Bleck TP
    Mayo Clin Proc; 1995 Feb; 70(2):195-6. PubMed ID: 7845048
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cardiac contractility in senile, insulin-dependent, diabetic patients. Changes that occur after the administration of glucose and insulin].
    Holgado Silva C; De La Vega Vázquez JM; Simón Morales E; Santis Scoccia C; Rodríguez Bernal A; Aznar Reig A
    Rev Clin Esp; 1979 Mar; 152(5):375-8. PubMed ID: 461882
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathogenesis of brain edema in fulminant hepatic failure.
    Blei AT
    Prog Liver Dis; 1995; 13():311-30. PubMed ID: 9224508
    [No Abstract]   [Full Text] [Related]  

  • 29. [Imbalance of amino acid metabolism in fulminant hepatitis and its management].
    Kato A; Suzuki K; Sato S
    Nihon Rinsho; 1992 Jul; 50(7):1599-603. PubMed ID: 1404890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements.
    Lesesne HR; Bozymski EM; Fallon HJ
    Gastroenterology; 1978 Feb; 74(2 Pt 1):169-73. PubMed ID: 340319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrolytes derangement in portal systemic encephalopathy (a preliminary study).
    Shahid A; Qureshi H; Zuberi SJ
    J Pak Med Assoc; 1985 Jul; 35(7):211-4. PubMed ID: 3930779
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Intravenous feeding.
    Flear CT
    Lancet; 1974 Apr; 1(7860):757-8. PubMed ID: 4132500
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute lung injury in fulminant hepatic failure following paracetamol poisoning.
    Baudouin SV; Howdle P; O'Grady JG; Webster NR
    Thorax; 1995 Apr; 50(4):399-402. PubMed ID: 7785015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience in the treatment of serious cardiac rhythm disorders with potassium, glucose and insulin.
    Ceremuzynski L; Kuch J
    Arch Inst Cardiol Mex; 1970; 40(2):186-94. PubMed ID: 5489739
    [No Abstract]   [Full Text] [Related]  

  • 36. Fulminant hepatic failure secondary to congestive heart failure.
    Kisloff B; Schaffer G
    Am J Dig Dis; 1976 Oct; 21(10):895-900. PubMed ID: 1015498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin and glucagon infusion in the treatment of liver failure.
    Jaspan JB; Landau RL; Schneider J
    Arch Intern Med; 1984 Oct; 144(10):2075-8. PubMed ID: 6385900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The critically ill liver patient: fulminant hepatic failure.
    McGuire BM
    Semin Gastrointest Dis; 2003 Jan; 14(1):39-42. PubMed ID: 12610854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.
    Wilkinson SP; Arroyo V; Gazzard BG; Moodie H; Williams R
    Lancet; 1974 Mar; 1(7857):521-4. PubMed ID: 4131970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.